Expert Q&A
Expert Q&A
11/09/2023
Stephen Biehl, RRT, RPFT
In this Q and A, Stephen Biehl, RRT, RPFT, answers questions about the guidelines from the American Thoracic Society on the use of race-specific equations in the interpretation of pulmonary function tests,...
11/09/2023
Expert Q&A
Expert Q&A
11/09/2023
Stephen Biehl, RRT, RPFT
In this Q and A, Stephen Biehl, RRT, RPFT, answers questions about the guidelines from the American Thoracic Society on the use of race-specific equations in the interpretation of pulmonary function tests,...
11/09/2023
Expert Q&A
Expert Q&A
11/09/2023
Stephen Biehl, RRT, RPFT
In this Q and A, Stephen Biehl, RRT, RPFT, answers questions about the guidelines from the American Thoracic Society on the use of race-specific equations in the interpretation of pulmonary function tests,...
11/09/2023
Expert Q&A
Expert Q&A
11/09/2023
Stephen Biehl, RRT, RPFT
In this Q and A, Stephen Biehl, RRT, RPFT, answers questions about the guidelines from the American Thoracic Society on the use of race-specific equations in the interpretation of pulmonary function tests,...
11/09/2023
Expert Q&A
Expert Q&A
10/30/2023
Ian Bouligny, MD
In this interview, Ian Bouligny, MD, answers questions about his team’s research that sought to determine the use of venetoclax-based strategies in patients with newly diagnosed secondary-type mutations of...
10/30/2023
Expert Q&A
Expert Q&A
10/30/2023
Ian Bouligny, MD
In this interview, Ian Bouligny, MD, answers questions about his team’s research that sought to determine the use of venetoclax-based strategies in patients with newly diagnosed secondary-type mutations of...
10/30/2023
Expert Q&A
Expert Q&A
10/30/2023
Ian Bouligny, MD
In this interview, Ian Bouligny, MD, answers questions about his team’s research that sought to determine the use of venetoclax-based strategies in patients with newly diagnosed secondary-type mutations of...
10/30/2023
Expert Q&A
Expert Q&A
10/30/2023
Ian Bouligny, MD
In this interview, Ian Bouligny, MD, answers questions about his team’s research that sought to determine the use of venetoclax-based strategies in patients with newly diagnosed secondary-type mutations of...
10/30/2023
Expert Q&A
Expert Q&A
10/30/2023
Ian Bouligny, MD
In this interview, Ian Bouligny, MD, answers questions about his team’s research that sought to determine the use of venetoclax-based strategies in patients with newly diagnosed secondary-type mutations of...
10/30/2023
Expert Q&A
Jordana Cohen
Expert Q&A
09/17/2023
In this Q&A, Jordana B. Cohen, MD, MSCE, assistant professor of medicine and epidemiology at the University of Pennsylvania School of Medicine, and a nephrologist and research scientist at the...
09/17/2023